Author

Bo Feng

Chinese Academy of Medical Sciences & Peking Union Medical College

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Gang Wen· 1 shared Gao ZhangiD· 1 shared Hongwei JiniD· 1 shared Jiaxin LiangiD· 1 shared Jie XiaiD· 1 shared Jishun LiiD· 1 shared Liang PengiD· 1 shared Mingli Yao· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Gang Wen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Discovery of novel 1,4-dicarbonylthiosemicarbazides as DNA gyrase inhibitors for the treatment of MRSA infection

Gao Zhang, Jiaxin Liang, Gang Wen, Mingli Yao, Yuqing Jia, Bo Feng, Jishun Li, Zunsheng Han, Qingxin Liu, Tianlei Li, Wenxuan Zhang, Hongwei Jin, Jie Xia, Liang Peng, Song Wu

The paper discovers a new class of DNA gyrase inhibitors, 1,4-dicarbonylthiosemicarbazides, with potent activity against MRSA through design, synthesis, and biological evaluation.

European Journal of Medicinal Chemistry · Sep 27, 2024Peer-reviewedPharmacology & Toxicology